Summary

Constellation Pharmaceuticals Inc

Founded in 2008

Description

Constellation Pharmaceuticals develops drugs in the field of epigenetics focusing on selective regulators of its function.

Strengths

  • Constellation Pharmaceuticals Inc has a strong market share in their industry
  • Revenue generated per employee is greater than industry average
  • Demonstrating revenue growth that is faster than the industry average
  • The number of employees is growing faster than the industry average
  • Since Constellation Pharmaceuticals Inc was founded, the company has grown faster than the industry average
  • Web traffic rankings are better than the industry average

Weaknesses

  • Variance of revenue growth is more than the industry average

Annual Revenue

Constellation Pharmaceuticals Inc's annual revenue

$28007000

Based on Kona Equity data

  • Revenue per employee

    $359064

  • Variance of revenue growth

    72.31

  • Annual revenue growth since founding

    $1750437

  • Revenue growth rate from first known quarter to current

    16279.3%

Employee Count

78 employees

  • Employee growth rate from first known quarter to current

    32.3%

Executives

Brad Prosek

Senior VP, Corporate Development

b**@constellationpharma.com

G Score - 6

The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.

  • G1 Revenue is greater than the industry median.
  • G2 Income per employee more than industry average.
  • G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
  • G4 Employee growth rate from the first known quarter to current is higher than the industry average.
  • G6 Annual revenue growth since founding is higher than the industry average.
  • G7 Website traffic rankings are better than the industry average

Web Analysis

  • Rank

    1.18 M

  • Page views per visitor

    3.0

  • Daily time

    2:51

  • Bounce Rate

    57.1 %

Location

215 FIRST St. Ste. 200 
Cambridge, MA  02142

Unlock unlimited leads

Get access to millions of contacts, companies, emails, and more!

Similar Companies

Checkmate Pharmaceuticals Inc.

checkmatepharma.com
  • Founded in 2015
  • Location: Cambridge, MA
  • Annual Revenue: $10.1M
  • Employees: 30
  • Empowering the immune system to beat back cancer

Karyopharm Therapeutics Inc

karyopharm.com
  • Founded in 2008
  • Location: Newton, MA
  • Annual Revenue: $157.1M
  • Employees: 385
  • Karyopharm Therapeutics is an innovation driven pharmaceutical company focused on the discovery, development, and commercialization of medicines with the goal of improving the lives of patients with cancer. Karyopharm Therapeutics is a clinical stage p...

Concert Pharmaceuticals Inc

concertpharma.com
  • Founded in 2006
  • Location: Lexington, Massachusetts
  • Annual Revenue: $32.6M
  • Employees: 64
  • Concert Pharmaceuticals is a biotechnology company utilizing deuterium to develop novel medical candidates. The company operates through the development of pharmaceutical products on its own behalf or in collaboration with others. Their product candida...

Arrakis Therapeutics Inc

arrakistx.com
  • Founded in 2015
  • Location: Waltham, MA
  • Annual Revenue: $49.0M
  • Employees: 28
  • Arrakis Therapeutics is a company that is pioneering the development of RNA targeted small molecule (rSM) therapies. They are on a mission to extend small molecule medicines into new realms of biology by unlocking the potential of RNA. Their approach i...

Pieris Pharmaceuticals Inc

pieris.com
  • Founded in 2001
  • Location: Boston, MA
  • Annual Revenue: $26.8M
  • Employees: 124
  • Pieris Pharmaceuticals is a clinical stage biotechnology company that discovers and develops Anticalin based drugs to target validated disease pathways. Their pipeline includes immuno oncology multi specifics tailored for the tumor micro environment, a...

Blueprint Medicines

blueprintmedicines.com
  • Founded in 2008
  • Location: Cambridge, MA
  • Annual Revenue: $204.0M
  • Employees: 641
  • Blueprint Medicines is a precision therapy company that invents life changing medicines for cancer and blood disorders.

Key Information

  • SIC: 28; 283
  • NAICS: 32541; 325412
Disclaimer: These numbers are estimates and any other company information is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona Equity is in no way affiliated with Constellation Pharmaceuticals Inc.

See similar companies

Frequently Asked Questions

Where is Constellation Pharmaceuticals Inc located?

Constellation Pharmaceuticals Inc's headquarters are located at 215 FIRST St. Ste. 200  Cambridge, MA  02142.


What is Constellation Pharmaceuticals Inc's official website?

Constellation Pharmaceuticals Inc's official website is constellationpharma.com


What is Constellation Pharmaceuticals Inc's revenue?

Constellation Pharmaceuticals Inc's annual revenue is $28.0 M.


What is Constellation Pharmaceuticals Inc's SIC code?

Constellation Pharmaceuticals Inc's SIC: 28; 283


What is Constellation Pharmaceuticals Inc's NAICS code?

Constellation Pharmaceuticals Inc's NAICS: 32541; 325412.


How many employees does Constellation Pharmaceuticals Inc's have?

Constellation Pharmaceuticals Inc has 78 employees


What industry does Constellation Pharmaceuticals Inc belong to?

Constellation Pharmaceuticals Inc is in the industry of Pharmaceuticals.

Next step

Visitors review